Immuneering Corporation (IMRX)

AI Score

Unlock

1.45

-0.01 (-0.68%)

At close: Apr 25, 2025, 3:59 PM

1.46

0.92%

After-hours: Apr 25, 2025, 04:32 PM EDT

Immuneering Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	36.14M	45.21M	59.73M	66.29M	59.41M	68.04M	104.02M	77.43M	72.64M	76.42M	87.94M	75.21M	74.89M	106.93M	50.25M	30.93M	37.09M	-13.78M
Short-Term Investments	n/a	5.45M	n/a	4.99M	26.26M	29.2M	4.97M	14.11M	32.89M	40.78M	40.16M	62.57M	74.31M	42.55M	n/a	n/a	n/a	27.56M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	4.96B	14.09B	n/a	n/a	n/a	n/a	996.56K	10.1M	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.3M	1.3M	1.23M	1.22M	1.03M	743.7K	743.7K	743.7K	743.7K	737.29K	89.58K	89.58K	102.13K	14.33K	960.39K	14.33K	14.33K	-13.78M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.05K	12.42K	70.18K	178.43K	279.61K	246.04K	471.38K	495.11K	492.4K	500.11K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	1.00	1.00	n/a	1.00	n/a	1.00	n/a	n/a
Other Current Assets	3.44M	n/a	3.96M	3.17M	3.42M	3.34M	2.52M	2.7M	3.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	39.59M	55.26M	63.69M	74.45M	89.08M	100.58M	111.51M	94.23M	108.75M	120.02M	129.17M	139.53M	152.33M	153.31M	51.44M	32.18M	37.73M	13.78M
Property-Plant & Equipment	4.79M	4.95M	5.12M	5.25M	5.4M	5.48M	5.56M	5.63M	5.78M	5.82M	5.68M	5.71M	6.13M	618.63K	644.85K	660.14K	677.47K	n/a
Goodwill & Intangibles	7.04M	7.05M	7.06M	7.06M	7.07M	7.08M	7.08M	7.09M	7.1M	7.11M	7.11M	7.12M	7.14M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.13M	13.3M	13.4M	13.54M	13.5M	13.3M	13.39M	13.46M	13.62M	13.67M	12.88M	12.92M	14.37M	10.73M	1.61M	674.47K	691.8K	-13.78M
Total Assets	52.71M	68.56M	77.09M	87.98M	102.58M	113.88M	124.9M	107.7M	122.37M	133.69M	142.05M	152.45M	166.7M	164.04M	53.04M	32.86M	38.42M	n/a
Account Payables	1.96M	1.94M	2.62M	2.27M	2.11M	1.94M	2.69M	2.72M	3.15M	2.34M	1.24M	1.64M	1.39M	1.8M	1.43M	1.37M	1.48M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	5.17M	n/a	2.43M	n/a	n/a	n/a	2.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.82M	59.66K	90.24K	23.63K	1.81M	1.03M	689.75K	26.33K	19.8K	44.56K	682.24K	47.21K	n/a	n/a	1.63M	n/a	163.67K	n/a
Total Current Liabilities	7.5M	6.92M	6.78M	5.18M	7.85M	5.62M	5.48M	5.53M	8.05M	7.26M	3.8M	3.67M	5.63M	5.27M	4.83M	2.76M	2.26M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.9K	9.9K	n/a	n/a	82.89M	n/a	58.1M	n/a
Total Long-Term Liabilities	3.82M	3.92M	4M	4.08M	4.16M	4.24M	4.31M	4.38M	4.46M	4.54M	4.65M	4.72M	5.09M	481.96K	83.4M	524.14K	58.65M	n/a
Total Liabilities	11.33M	10.84M	10.78M	9.26M	12.01M	9.86M	9.79M	9.91M	12.52M	11.8M	8.46M	8.39M	10.72M	5.75M	88.23M	3.28M	60.9M	n/a
Total Debt	4.16M	4.24M	4.31M	4.38M	4.46M	4.54M	4.64M	4.74M	4.84M	4.85M	4.93M	4.97M	5.36M	564.76K	583.82K	602.59K	621.09K	n/a
Common Stock	31.05K	31.05K	29.65K	29.65K	29.27K	29.27K	29.26K	26.5K	26.42K	26.41K	26.39K	26.38K	26.32K	25.94K	5.28K	13.51K	4.95K	n/a
Retained Earnings	-224.3M	-206.24M	-191.65M	-177.57M	-163.26M	-148.18M	-135.58M	-123.39M	-109.79M	-96.54M	-83.7M	-72.17M	-59.27M	-48.49M	-39.95M	-31.97M	-25.74M	n/a
Comprehensive Income	n/a	7.84K	n/a	-1.08K	-778	5.61K	-2.22K	506.00	-30.12K	-142.47K	-181.56K	-167.4K	-49.01K	-4.75K	-149.42B	-58.1M	-58.1M	-6.53M
Shareholders Equity	41.39M	57.72M	66.31M	78.72M	90.58M	104.02M	115.1M	97.79M	109.85M	121.89M	133.59M	144.06M	155.98M	158.29M	-35.19M	29.57M	-22.48M	10.08M
Total Investments	n/a	5.45M	n/a	4.99M	26.26M	29.2M	4.97B	14.11B	32.89M	40.78M	40.16M	62.57M	74.31M	52.65M	n/a	n/a	n/a	27.56M